As of 9th December 2024, ZYDUSLIFE stock is exhibiting robust technical strength at ₹1030, with an upward trajectory that positions it as a notable performer in the pharmaceutical sector. The stock shows healthy daily trading volumes averaging 2.5 million shares, demonstrating strong institutional interest and market confidence. This price point marks a strategic level for investors, as it coincides with the stock's 50-day moving average and represents a 15% appreciation from its previous quarter's average, suggesting sustained bullish momentum in the near term.